|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02587 HEALTHYWAY INC
Nominal 
4.680 -0.200 (-4.098%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 1,200,775 | 1,244,458 | 569,068 | 431,305 |
| Cost of Sales | -- | -- | (834,864) | (846,222) | (323,273) | (257,832) |
| Gross Profit | -- | -- | 365,911 | 398,236 | 245,795 | 173,473 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (272,772) | (324,779) | (267,834) | (84,370) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (286) | (72) | 891 | (112) | |
| Profit / (Loss) before Taxation | -- | -- | (263,799) | (320,945) | (257,605) | (152,083) | |
| Taxation | -- | -- | (5,359) | 7,063 | 1,966 | (3,224) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 702 | 3,803 | (2,492) | (1,916) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 55,682 | -- | (268,456) | (310,079) | (258,131) | (157,223) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 3,365 | 2,571 | 1,387 | 613 |
| Depreciation & Amortisation | -- | -- | 38,273 | 19,542 | 2,536 | 3,702 |
| Directors' Emoluments | -- | -- | 1,145 | 976 | 1,072 | 450 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 6.000 | -- | -38.000 | -44.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.079 | 0.005 | -- | -- |
| NBV per share ($) | -- | -- | 0.258 | -- | -- | -- |
| Remarks: | Real time quote last updated: 31/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 55,682 |
| %Change | -- |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB -- |